Skip to main content
logo
Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.700
+0.210 (6.02%)
Aug 4, 2026, 4:00 PM EDT - Market closed

Cyclerion Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.992.072-0.33.94
Revenue Growth
-4.23%3.70%---92.47%71.69%
Gross Profit
1.992.072-0.33.94
Selling, General & Admin
7.076.095.348.1312.8620.62
Research & Development
1.650.960.291.525.9837.64
Other Operating Expenses
---3.3-0.88
Total Operating Expenses
8.727.055.6312.9518.8459.14
Operating Income
-6.73-4.97-3.63-12.95-18.54-55.2
Interest Income
0.130.130.210.360.29-0.02
Other Non-Operating Income (Expense)
1.321.320.36--3.56
Total Non-Operating Income (Expense)
1.451.450.570.360.293.55
Pretax Income
-5.28-3.53-3.06-12.59-18.25-51.65
Net Income
-5.28-3.53-3.06-12.59-18.25-51.65
Earnings From Discontinued Operations
---7.33-25.83-
Net Income to Common
-5.28-3.53-3.06-5.26-44.08-51.65
Net Income Growth
------
Shares Outstanding (Basic)
533222
Shares Outstanding (Diluted)
533222
Shares Change
32.12%26.33%7.70%7.59%11.03%28.75%
EPS (Basic)
-1.36-1.11-1.21-2.25-8.40-26.40
EPS (Diluted)
-1.36-1.11-1.21-2.25-8.40-26.40
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3.59-3.31-4.33-21.25-40.61-36.52
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.72-1.04-1.72-9.09-18.69-18.66
Gross Margin
100.00%100.00%100.00%-100.00%100.00%
Operating Margin
-337.43%-239.78%-181.40%--6242.42%-1400.18%
Profit Margin
-264.73%-170.11%-152.85%--6143.43%-1310.17%
FCF Margin
-180.03%-159.79%-216.65%--13673.70%-926.53%
EBITDA
-6.73-4.97-3.63-12.95-18.48-54.72
EBITDA Margin
-337.43%-239.78%-181.40%--6220.54%-1388.20%
EBIT
-6.73-4.97-3.63-12.95-18.54-55.2
EBIT Margin
-337.43%-239.78%-181.40%--6242.42%-1400.18%
SEC Filings: 10-K · 10-Q